MFS
SRPT icon

Mirabella Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Mirabella Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,492
Closed -$1.09M – 602
2023
Q2 		$1.09M Buy
+9,492
New +$1.22M 0.12% 192
2023
Q1 		– Sell
-21,096
Closed -$2.73M – 583
2022
Q4 		$2.73M Buy
+21,096
New +$2.44M 0.24% 71

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mirabella Financial Services's SRPT Position: Q3 2023 in Review

Mirabella Financial Services sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 9,492 shares — an estimated $1.09M sold.

Mirabella Financial Services first reported a position in SRPT in Q4 2022 and held it in 2 quarters. The position peaked at $2.73M in Q4 2022. 394 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • Mirabella Financial Services reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 9,492 Sarepta Therapeutics shares in Q3 2023, an estimated $1.09M.
  • Mirabella Financial Services first reported a position in Sarepta Therapeutics in Q4 2022 and held it in 2 quarters.
  • Mirabella Financial Services's Sarepta Therapeutics position peaked at $2.73M in Q4 2022.
  • 394 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on Mirabella Financial Services's 13F filing for Q3 2023, filed 13 Nov 2023.